SYSTEMIC LUPUS ERYTHEMATOSUS
Clinical trials for SYSTEMIC LUPUS ERYTHEMATOSUS explained in plain language.
Never miss a new study
Get alerted when new SYSTEMIC LUPUS ERYTHEMATOSUS trials appear
Sign up with your email to follow new studies for SYSTEMIC LUPUS ERYTHEMATOSUS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Targeted drug combo tested to tame lupus flares
Disease control TerminatedThis study aimed to see if two different drug combinations could better control active systemic lupus erythematosus (SLE) in specific groups of patients. It tested mycophenolate mofetil (MMF) alone or combined with voclosporin in adults with moderate to severe, non-organ-threaten…
Matched conditions: SYSTEMIC LUPUS ERYTHEMATOSUS
Phase: PHASE2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated Mar 27, 2026 12:41 UTC
-
Race for better lupus treatment: drug trial halted early
Disease control TerminatedThis study tested whether a new drug called telitacicept could help control moderate-to-severe lupus symptoms better than a placebo. It involved 91 patients aged 12-70 who continued their standard lupus medications. The trial was terminated early, so the full results are not avai…
Matched conditions: SYSTEMIC LUPUS ERYTHEMATOSUS
Phase: PHASE3 • Sponsor: Vor Biopharma • Aim: Disease control
Last updated Mar 20, 2026 14:48 UTC